Telix Pharmaceuticals (ASX:TLX) received notice that its Chief Executive Christian Behrenbruch sold 2 million shares in the company at AU$29.50 per share by way of a block trade, according to a Thursday Australian bourse filing.

Behrenbruch now holds shares equal to about 6.3% of the company's issued capital and has no intention to sell them, the filing said.

Additionally, the company's co-founder Andreas Kluge sold 2 million shares in the company for the same price.

Company shares were down nearly 2% in recent Thursday trade.